RAPID RESPONSE WITH UPADACITINIB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CSDMARDS OR BDMARDS

被引：2

作者：

FitzGerald, O. ^{[1
,2
]}

Rubbert-Roth, A. ^{[3
]}

Chen, K. ^{[4
]}

Meerwein, S. ^{[5
]}

Enejosa, J. ^{[4
]}

Shaw, T. ^{[4
]}

Wells, A. F. ^{[6
]}

机构：

[1] Univ Coll Dublin, St Vincents Univ Hosp, Dublin, Ireland

[2] Univ Coll Dublin, Conway Inst, Dublin, Ireland

[3] Kantonsspital St Gallen, St Gallen, Switzerland

[4] AbbVie, N Chicago, IL USA

[5] AbbVie Deutschland, Ludwigshafen, Germany

[6] Rheum & Immunotherapy Ctr, Franklin, TN USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷

关键词：

D O I：

10.1136/annrheumdis-2018-eular.4221

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SAT0239

引用

页码：981 / 981

页数：1

共 50 条

[21] SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS
Kavanaugh, Arthur
Buch, Maya
Combe, Bernard
Bessette, Louis
Song, In-Ho
Song, Yanna
Suboticki, Jessica
Nash, Peter
INTERNAL MEDICINE JOURNAL, 2021, 51 : 46 - 46
[22] Sustainability of Response to Upadacitinib as Monotherapy or in Combination Among Patients with Rheumatoid Arthritis and Prior Inadequate Response to Conventional Synthetic DMARDs
Kavanaugh, Arthur
Buch, Maya
Combe, Bernard
Bessette, Louis
Song, In-Ho
Song, Yanna
Suboticki, Jessica
Nash, Peter
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[23] SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS
Kavanaugh, A.
Buch, M. H.
Combe, B.
Bessette, L.
Song, I. H.
Song, Y.
Suboticki, J.
Nash, P.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 323 - 324
[24] Patient Disease Trajectories in Baricitinib-2mg-treated Patients with Rheumatoid Arthritis and Inadequate Response to csDMARDs
Pope, Janet
Li, Zhanguo
Genovese, Mark
Otawa, Susan
Sun, Luna
Chandran, Shelly
Keystone, Edward
Dougados, Maxime
JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1127 - 1128
[25] SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE
Fleischmann, Roy
Meerwein, Sebastian
Charles-Schoeman, Christina
Combe, Bernard
Hall, Stephen
Khan, Nasser
Carter, Kyle
Camp, Heidi
Rubbert-Roth, Andrea
INTERNAL MEDICINE JOURNAL, 2023, 53 : 43 - 43
[26] Upadacitinib Monotherapy Improves Patient-Reported Outcomes in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate
Strand, Vibeke
Buch, Maya
Tundia, Namita
Camp, Heidi S.
Suboticki, Jessica
Goldschmidt, Debbie
Wells, Alvin F.
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[27] Upadacitinib in patients from China, Brazil, and South Korea with rheumatoid arthritis and an inadequate response to conventional therapy
Zeng, Xiaofeng
Zhao, Dongbao
Radominski, Sebastiao C.
Keiserman, Mauro
Lee, Chang K.
Meerwein, Sebastian
Enejosa, Jeffrey
Sui, Yunxia
Mohamed, Mohamed-Eslam F.
Park, Won
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (12) : 1530 - 1539
[28] EVALUATION OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO FIRST-GENERATION JANUS KINASE INHIBITORS
Kamiya, M.
Mori, S.
Yamazaki, K.
Togawa, D.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 608 - 608
[29] TREATMENT PATTERNS, PERSISTENCE, AND DURABILITY IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (BDMARDS)
Dore, Robin K.
Antonova, Jenya
Burudpakdee, Chakkarin
Wang, Xin
Ozbay, Burak
Genovese, Mark C.
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1135 - 1136
[30] The efficacy of tofacitinib combined with bDMARDs in the treatment of ankylosing spondylitis patients with inadequate response to bDMARDs: a retrospective study
Jie Chang
Gang Wang
BMC Rheumatology, 8

← 1 2 3 4 5 →